WO2010151746A3 - Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure - Google Patents

Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure Download PDF

Info

Publication number
WO2010151746A3
WO2010151746A3 PCT/US2010/039962 US2010039962W WO2010151746A3 WO 2010151746 A3 WO2010151746 A3 WO 2010151746A3 US 2010039962 W US2010039962 W US 2010039962W WO 2010151746 A3 WO2010151746 A3 WO 2010151746A3
Authority
WO
WIPO (PCT)
Prior art keywords
dimensional
microfiber extrudate
extrudate structure
dimensional microfiber
forming
Prior art date
Application number
PCT/US2010/039962
Other languages
French (fr)
Other versions
WO2010151746A2 (en
Inventor
Peter D. Gabriele
Andrew Hogan
Original Assignee
Armark Authentication Technologies, Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Armark Authentication Technologies, Llc filed Critical Armark Authentication Technologies, Llc
Publication of WO2010151746A2 publication Critical patent/WO2010151746A2/en
Publication of WO2010151746A3 publication Critical patent/WO2010151746A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Abstract

Disclosed is a three-dimensional microfiber extrudate structure and a process of forming a three-dimensional microfiber extrudate structure. The three-dimensional microfiber extrudate structure includes a matrix having a three-dimensional geometry wherein the three-dimensional geometry is a visco-elastic relaxation state of a preform introduced to a medium.
PCT/US2010/039962 2009-06-26 2010-06-25 Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure WO2010151746A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22077009P 2009-06-26 2009-06-26
US61/220,770 2009-06-26

Publications (2)

Publication Number Publication Date
WO2010151746A2 WO2010151746A2 (en) 2010-12-29
WO2010151746A3 true WO2010151746A3 (en) 2011-12-29

Family

ID=42352903

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2010/039962 WO2010151746A2 (en) 2009-06-26 2010-06-25 Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure

Country Status (1)

Country Link
WO (1) WO2010151746A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2822558B1 (en) 2012-03-06 2020-02-19 The Board of Trustees of the University of Illionis Procaspase 3 activation by combination therapy
US11510919B2 (en) 2017-11-17 2022-11-29 The Board Of Trustees Of The University Of Illinois Cancer therapy by degrading dual MEK signaling

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
EP0709086A2 (en) * 1994-10-28 1996-05-01 Fuisz Technologies Ltd. Discrete particles and method of making same
WO2000035423A1 (en) * 1998-12-16 2000-06-22 Aventis Pharmaceuticals Inc. Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
WO2002094226A1 (en) * 2001-05-23 2002-11-28 Hexal Ag Homogenised product for implants and microparticles
WO2009088777A1 (en) * 2007-12-31 2009-07-16 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4640035A (en) 1981-09-03 1987-02-03 The Secretary Of State For Defence In Her Britannic Majesty's Government Of The United Kingdom Of Great Britain And Northern Ireland Identifying means
KR950001645B1 (en) 1987-10-02 1995-02-27 바스프 코포레이션 Profiled multi-component fibers and method and apparatus for making the same
US5162074A (en) 1987-10-02 1992-11-10 Basf Corporation Method of making plural component fibers
US6861142B1 (en) 2002-06-06 2005-03-01 Hills, Inc. Controlling the dissolution of dissolvable polymer components in plural component fibers
WO2007134192A2 (en) 2006-05-10 2007-11-22 Armark Authentication Technologies, Inc. Extruded filament for microscopic tagging system

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3922339A (en) * 1974-06-20 1975-11-25 Kv Pharm Co Sustained release medicant
EP0709086A2 (en) * 1994-10-28 1996-05-01 Fuisz Technologies Ltd. Discrete particles and method of making same
WO2000035423A1 (en) * 1998-12-16 2000-06-22 Aventis Pharmaceuticals Inc. Biodegradable polymer encapsulated serotonin receptor antagonist and method for preparing the same
WO2002094226A1 (en) * 2001-05-23 2002-11-28 Hexal Ag Homogenised product for implants and microparticles
WO2009088777A1 (en) * 2007-12-31 2009-07-16 Armark Authentication Technologies, Llc Article and method for focused delivery of therapeutic and/or diagnostic materials

Also Published As

Publication number Publication date
WO2010151746A2 (en) 2010-12-29

Similar Documents

Publication Publication Date Title
EP2494107A4 (en) Process for production of microfibrillated cellulose in an extruder and microfibrillated cellulose produced according to the process
PL1999134T3 (en) Process for the production of anhydrosugar alcohols
IL213633A (en) Method for reducing the recalcitrance of a biomass feedstock and a method for producing a product
ZA201200329B (en) Process for the production of microfibrillated cellulose and produced microfibrillated cellulose
EP2436700B8 (en) Shortened purification process for the production of capsular streptococcus pneumoniae polysaccharides
EP2508671B8 (en) Cellulose nanofibers and method of producing cellulose nanofibers
EP2223951A4 (en) Process for production of polycarbonate and moldings of polycarbonate
IL198342A0 (en) Process for the biological production of n-butanol with high yield
ZA201201468B (en) Microorganisms and methods for the co-production of isopropanol with primary alcohols, diols and acids
PL2212456T3 (en) Process for the production of a hydroentangled product comprising cellulose fibers
ZA201102728B (en) Process for the production of alcohol
PT2449121T (en) Alcohol production process
EP2391724A4 (en) Alcohol production process
EP2034026A4 (en) Process for production of optically active alcohol
PL2430196T3 (en) Process for the production of alcohols
EP2170798A4 (en) High shear process for the production of acetaldehyde
EP2019133A4 (en) MICROORGANISM CAPABLE OF PRODUCING gamma-L-PGA, METHOD FOR PRODUCTION OF gamma-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN
EP2011860A4 (en) Bacterium capable of producing purine substance, and process for production of purine substance
EP2089204A4 (en) Non-petroleum-based polyurethane foam products having improved performance specifications and method of production
HK1167628A1 (en) Process for producing an injection-moulded decorative item and injection- moulded item
EP2011861A4 (en) Bacterium capable of producing purine substance, and process for production of purine substance
EP2408346B8 (en) Method for continuously producing sponge bodies made of regenerated cellulose and a sponge body
EP2137100A4 (en) High shear process for the production of chloral
EP2581148A4 (en) Process for production of molds
WO2010151746A3 (en) Three-dimensional microfiber extrudate structure and process for forming three-dimensional microfiber extrudate structure

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10730305

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10730305

Country of ref document: EP

Kind code of ref document: A2